--- title: "DEXCOM INC (DXCM) stock listing, news and investor profile" url: "https://aibio.space/companies/dexcom/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "DEXCOM INC (NASDAQ: DXCM), United States. Listing facts, related biotech companies and news on aibio.space." --- DXCM DEXCOM INC NASDAQ · United States # DEXCOM INC (DXCM) news DEXCOM INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker DXCM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest DEXCOM INC news We have not published a story on DEXCOM INC yet. When there is news, it will appear here. ## DEXCOM INC at a glance - **Ticker**: DXCM - **Listing**: NASDAQ - **Country**: United States - **Cash, Sep 30, 2026**: $961.4 million ### Related companies - [Embecta](https://aibio.space/companies/embecta/) NASDAQ: EMBC - [Zoetis](https://aibio.space/companies/zoetis/) NYSE: ZTS - [Cryoport](https://aibio.space/companies/cryoport/) NASDAQ: CYRX - [Stimcell Energetics](https://aibio.space/companies/stimcell-energetics/) OTC: STME - [Polomar Health Services](https://aibio.space/companies/polomar-health-services/) OTC: PMHS - [Lifeward](https://aibio.space/companies/lifeward/) NASDAQ: LFWD - [Alpha Tau Medical](https://aibio.space/companies/alpha-tau-medical/) NASDAQ: DRTS - [OmniAb](https://aibio.space/companies/omniab/) NASDAQ: OABI ### Also on NASDAQ - [Protara Therapeutics](https://aibio.space/companies/protara-therapeutics/) TARA - [Relay Therapeutics](https://aibio.space/companies/relay-therapeutics/) RLAY - [SciSparc](https://aibio.space/companies/scisparc/) SPRC - [Sionna Therapeutics](https://aibio.space/companies/sionna-therapeutics/) SION - [MapLight Therapeutics](https://aibio.space/companies/maplight-therapeutics/) MPLT - [Precision BioSciences](https://aibio.space/companies/precision-biosciences/) DTIL ## DEXCOM INC annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$599.1 million](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/) | [$552.4 million](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/) | | Net income (loss) | [$836.3 million](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/) | [$576.2 million](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/) | | Cash from operations | [$1.44 billion](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/) | [$989.5 million](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/) | | Cash and equivalents | [$917.7 million](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000195/) | [$606.1 million](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/) | | Short-term investments | | [$1.73 billion](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000113/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $961.4 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about DEXCOM INC What is the ticker symbol of DEXCOM INC? DEXCOM INC trades under the ticker DXCM on NASDAQ. Where is DEXCOM INC listed? DEXCOM INC is listed on NASDAQ. Which country or territory is DEXCOM INC listed under? Our directory records DEXCOM INC under United States. Does aibio.space cover DEXCOM INC? aibio.space lists DEXCOM INC among 2,820 public biotech companies and publishes its news here as stories appear. Is DEXCOM INC profitable? DEXCOM INC reported net income of $836.3 million for the fiscal year ended Dec 31, 2025, and generated $1.44 billion of cash from operations, per its annual report to the SEC. How much does DEXCOM INC spend on research and development? $599.1 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does DEXCOM INC have? $961.4 million in cash at Sep 30, 2026, per its 10-Q. ## Investor discussion: DEXCOM INC Members talk about DEXCOM INC (DXCM). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at DEXCOM INC, newest first. Each line links the filing it comes from. 1. 2026-05-15 Financings Announced a share repurchase program. SEC Form 8-K (Items 7.01,8.01). [Source](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000085/dxcm-20260514.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:DXCM on TradingView](https://www.tradingview.com/symbols/NASDAQ-DXCM/). ## Listing details DEXCOM INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker DXCM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: DEXCOM INC - **Ticker**: DXCM - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/dexcom/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "DEXCOM INC (DXCM) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/dexcom/